American International Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,229
| Closed | -$42.4K | – | 38 |
|
|
2024
Q1 | $42.4K | Sell |
34,229
-294
| -0.9% | -$365 | ﹤0.01% | 2820 |
|
|
2023
Q4 | $36.2K | Sell |
34,523
-138
| -0.4% | -$145 | ﹤0.01% | 2878 |
|
|
2023
Q3 | $237K | Buy |
34,661
+1,232
| +4% | +$8.44K | ﹤0.01% | 2033 |
|
|
2023
Q2 | $347K | Buy |
33,429
+2,249
| +7% | +$23.3K | ﹤0.01% | 1868 |
|
|
2023
Q1 | $252K | Buy |
31,180
+620
| +2% | +$5.02K | ﹤0.01% | 1987 |
|
|
2022
Q4 | $481K | Sell |
30,560
-110
| -0.4% | -$1.73K | ﹤0.01% | 1612 |
|
|
2022
Q3 | $483K | Buy |
30,670
+2,669
| +10% | +$42K | ﹤0.01% | 1595 |
|
|
2022
Q2 | $391K | Buy |
28,001
+2,678
| +11% | +$37.4K | ﹤0.01% | 1774 |
|
|
2022
Q1 | $437K | Sell |
25,323
-1,783
| -7% | -$30.8K | ﹤0.01% | 1797 |
|
|
2021
Q4 | $394K | Sell |
27,106
-811
| -3% | -$11.8K | ﹤0.01% | 1960 |
|
|
2021
Q3 | $503K | Buy |
27,917
+3,589
| +15% | +$64.7K | ﹤0.01% | 1853 |
|
|
2021
Q2 | $427 | Buy |
+24,328
| New | +$427 | ﹤0.01% | 2025 |
|
|
2020
Q2 | – | Sell |
-18,241
| Closed | -$19K | – | 3105 |
|
|
2020
Q1 | $19K | Sell |
18,241
-1,053
| -5% | -$1.1K | ﹤0.01% | 2934 |
|
|
2019
Q4 | $36K | Sell |
19,294
-163
| -0.8% | -$304 | ﹤0.01% | 2949 |
|
|
2019
Q3 | $21K | Sell |
19,457
-135
| -0.7% | -$146 | ﹤0.01% | 3019 |
|
|
2019
Q2 | $43K | Sell |
19,592
-2,984
| -13% | -$6.55K | ﹤0.01% | 2975 |
|
|
2019
Q1 | $135K | Sell |
22,576
-731
| -3% | -$4.37K | ﹤0.01% | 2438 |
|
|
2018
Q4 | $172K | Buy |
23,307
+5,575
| +31% | +$41.1K | ﹤0.01% | 2268 |
|
|
2018
Q3 | $257K | Buy |
17,732
+318
| +2% | +$4.61K | ﹤0.01% | 2276 |
|
|
2018
Q2 | $348K | Buy |
17,414
+2,554
| +17% | +$51K | ﹤0.01% | 2050 |
|
|
2018
Q1 | $260K | Sell |
14,860
-799
| -5% | -$14K | ﹤0.01% | 2124 |
|
|
2017
Q4 | $386K | Buy |
15,659
+2,147
| +16% | +$52.9K | ﹤0.01% | 1931 |
|
|
2017
Q3 | $349K | Buy |
13,512
+1,010
| +8% | +$26.1K | ﹤0.01% | 1968 |
|
|
2017
Q2 | $339K | Buy |
12,502
+5,698
| +84% | +$155K | ﹤0.01% | 1954 |
|
|
2017
Q1 | $203K | Buy |
6,804
+1,623
| +31% | +$48.4K | ﹤0.01% | 2175 |
|
|
2016
Q4 | $141K | Sell |
5,181
-14
| -0.3% | -$381 | ﹤0.01% | 2394 |
|
|
2016
Q3 | $133K | Buy |
5,195
+7
| +0.1% | +$179 | ﹤0.01% | 2439 |
|
|
2016
Q2 | $95.8K | Buy |
5,188
+1,867
| +56% | +$34.5K | ﹤0.01% | 2634 |
|
|
2016
Q1 | $63K | Buy |
+3,321
| New | +$63K | ﹤0.01% | 3734 |
|